Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY TREATMENT INDUSTRY
2.1 Summary about Chemotherapy Induced Peripheral Neuropathy Treatment Industry
2.2 Chemotherapy Induced Peripheral Neuropathy Treatment Market Trends
2.2.1 Chemotherapy Induced Peripheral Neuropathy Treatment Production & Consumption Trends
2.2.2 Chemotherapy Induced Peripheral Neuropathy Treatment Demand Structure Trends
2.3 Chemotherapy Induced Peripheral Neuropathy Treatment Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 APX-3330
4.2.2 BR-297
4.2.3 Cannabidiol
4.2.4 Dimiracetam
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Clinic
4.3.2 Hospital
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 APX-3330
5.2.2 BR-297
5.2.3 Cannabidiol
5.2.4 Dimiracetam
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Clinic
5.3.2 Hospital
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 APX-3330
6.2.2 BR-297
6.2.3 Cannabidiol
6.2.4 Dimiracetam
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Clinic
6.3.2 Hospital
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 APX-3330
7.2.2 BR-297
7.2.3 Cannabidiol
7.2.4 Dimiracetam
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Clinic
7.3.2 Hospital
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 APX-3330
8.2.2 BR-297
8.2.3 Cannabidiol
8.2.4 Dimiracetam
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Clinic
8.3.2 Hospital
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 APX-3330
9.2.2 BR-297
9.2.3 Cannabidiol
9.2.4 Dimiracetam
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Clinic
9.3.2 Hospital
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Achelios Therapeutics Inc
10.1.2 Advinus Therapeutics Ltd
10.1.3 Apollo Endosurgery Inc
10.1.4 Aptinyx Inc
10.1.5 Asahi Kasei Pharma Corp
10.1.6 Can-Fite BioPharma Ltd
10.1.7 Celgene Corp
10.1.8 DermaXon LLC
10.1.9 Eisai
10.1.10 Immune Pharmaceuticals Inc
10.1.11 INSYS Therapeutics Inc
10.1.12 Kineta Inc
10.1.13 KPI Therapeutics Inc
10.1.14 Krenitsky Pharmaceuticals Inc
10.1.15 MAKScientific LLC
10.1.16 Metys Pharmaceuticals AG
10.1.17 Midatech Pharma US Inc
10.1.18 Mundipharma International Ltd
10.1.19 Nemus Bioscience Inc
10.1.20 Neurocentrx Pharma Ltd
10.1.21 Panacea Pharmaceuticals Inc
10.1.22 PeriphaGen Inc
10.1.23 PharmatrophiX Inc
10.1.24 PledPharma AB
10.1.25 Sova Pharmaceuticals Inc
10.1.26 Virobay Inc
10.1.27 WEX Pharmaceuticals Inc
10.2 Chemotherapy Induced Peripheral Neuropathy Treatment Sales Date of Major Players (2017-2020e)
10.2.1 Achelios Therapeutics Inc
10.2.2 Advinus Therapeutics Ltd
10.2.3 Apollo Endosurgery Inc
10.2.4 Aptinyx Inc
10.2.5 Asahi Kasei Pharma Corp
10.2.6 Can-Fite BioPharma Ltd
10.2.7 Celgene Corp
10.2.8 DermaXon LLC
10.2.9 Eisai
10.2.10 Immune Pharmaceuticals Inc
10.2.11 INSYS Therapeutics Inc
10.2.12 Kineta Inc
10.2.13 KPI Therapeutics Inc
10.2.14 Krenitsky Pharmaceuticals Inc
10.2.15 MAKScientific LLC
10.2.16 Metys Pharmaceuticals AG
10.2.17 Midatech Pharma US Inc
10.2.18 Mundipharma International Ltd
10.2.19 Nemus Bioscience Inc
10.2.20 Neurocentrx Pharma Ltd
10.2.21 Panacea Pharmaceuticals Inc
10.2.22 PeriphaGen Inc
10.2.23 PharmatrophiX Inc
10.2.24 PledPharma AB
10.2.25 Sova Pharmaceuticals Inc
10.2.26 Virobay Inc
10.2.27 WEX Pharmaceuticals Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Chemotherapy Induced Peripheral Neuropathy Treatment Product Type Overview
2.Table Chemotherapy Induced Peripheral Neuropathy Treatment Product Type Market Share List
3.Table Chemotherapy Induced Peripheral Neuropathy Treatment Product Type of Major Players
4.Table Brief Introduction of Achelios Therapeutics Inc
5.Table Brief Introduction of Advinus Therapeutics Ltd
6.Table Brief Introduction of Apollo Endosurgery Inc
7.Table Brief Introduction of Aptinyx Inc
8.Table Brief Introduction of Asahi Kasei Pharma Corp
9.Table Brief Introduction of Can-Fite BioPharma Ltd
10.Table Brief Introduction of Celgene Corp
11.Table Brief Introduction of DermaXon LLC
12.Table Brief Introduction of Eisai
13.Table Brief Introduction of Immune Pharmaceuticals Inc
14.Table Brief Introduction of INSYS Therapeutics Inc
15.Table Brief Introduction of Kineta Inc
16.Table Brief Introduction of KPI Therapeutics Inc
17.Table Brief Introduction of Krenitsky Pharmaceuticals Inc
18.Table Brief Introduction of MAKScientific LLC
19.Table Brief Introduction of Metys Pharmaceuticals AG
20.Table Brief Introduction of Midatech Pharma US Inc
21.Table Brief Introduction of Mundipharma International Ltd
22.Table Brief Introduction of Nemus Bioscience Inc
23.Table Brief Introduction of Neurocentrx Pharma Ltd
24.Table Brief Introduction of Panacea Pharmaceuticals Inc
25.Table Brief Introduction of PeriphaGen Inc
26.Table Brief Introduction of PharmatrophiX Inc
27.Table Brief Introduction of PledPharma AB
28.Table Brief Introduction of Sova Pharmaceuticals Inc
29.Table Brief Introduction of Virobay Inc
30.Table Brief Introduction of WEX Pharmaceuticals Inc
31.Table Products & Services of Achelios Therapeutics Inc
32.Table Products & Services of Advinus Therapeutics Ltd
33.Table Products & Services of Apollo Endosurgery Inc
34.Table Products & Services of Aptinyx Inc
35.Table Products & Services of Asahi Kasei Pharma Corp
36.Table Products & Services of Can-Fite BioPharma Ltd
37.Table Products & Services of Celgene Corp
38.Table Products & Services of DermaXon LLC
39.Table Products & Services of Eisai
40.Table Products & Services of Immune Pharmaceuticals Inc
41.Table Products & Services of INSYS Therapeutics Inc
42.Table Products & Services of Kineta Inc
43.Table Products & Services of KPI Therapeutics Inc
44.Table Products & Services of Krenitsky Pharmaceuticals Inc
45.Table Products & Services of MAKScientific LLC
46.Table Products & Services of Metys Pharmaceuticals AG
47.Table Products & Services of Midatech Pharma US Inc
48.Table Products & Services of Mundipharma International Ltd
49.Table Products & Services of Nemus Bioscience Inc
50.Table Products & Services of Neurocentrx Pharma Ltd
51.Table Products & Services of Panacea Pharmaceuticals Inc
52.Table Products & Services of PeriphaGen Inc
53.Table Products & Services of PharmatrophiX Inc
54.Table Products & Services of PledPharma AB
55.Table Products & Services of Sova Pharmaceuticals Inc
56.Table Products & Services of Virobay Inc
57.Table Products & Services of WEX Pharmaceuticals Inc
58.Table Market Distribution of Major Players
59.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
60.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
61.Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast (Million USD) by Region 2021f-2026f
62.Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast (Million USD) Share by Region 2021f-2026f
63.Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast (Million USD) by Demand 2021f-2026f
64.Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f